← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Children'S Hospital (New Orleans)
New Orleans, LA
$12,606,985
Total funding
18
Grants
Funding over time
peak $1.9M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,606,985 · 18
By mechanism
R01$9,960,359 · 9
R21$976,173 · 2
R56$764,376 · 2
K22$486,000 · 1
R03$387,910 · 3
U01$32,167 · 1
Investigators at Children'S Hospital (New Orleans)
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Mechanisms of Antibody-Mediated Toxin Neutralization$489,550
R01 · FY2006 · AI
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H$475,109
R01 · FY2010 · AI
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H$469,129
R01 · FY2012 · AI
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H$469,048
R01 · FY2011 · AI
Mechanisms of Antibody-Mediated Toxin Neutralization$436,891
R01 · FY2007 · AI
Atypical G protein signaling in Cryptococcus neoformans$396,250
R01 · FY2009 · AI
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H$391,526
R56 · FY2008 · AI
Atypical G protein signaling in Cryptococcus neoformans$372,850
R56 · FY2008 · AI
Mechanisms of Antibody-Mediated Toxin Neutralization$357,500
R01 · FY2005 · AI
Atypical G protein signaling in Cryptococcus neoformans$356,625
R01 · FY2010 · AI
Microbial Correlates of Bacterial Vaginosis Treatment Failure and Recurrence in H$328,847
R01 · FY2009 · AI
Candida albicans Surface Antigens$315,000
R01 · FY2002 · AI
Candida albicans Surface Antigens$315,000
R01 · FY2005 · AI
Candida albicans Surface Antigens$315,000
R01 · FY2003 · AI
Candida albicans Surface Antigens$315,000
R01 · FY2004 · AI
Impact of Biological Variation in A1c on Mortality, Cardiovascular Events, and Hy$305,584
R01 · FY2011 · HL
B-cells in pups of mild and severe STZ diabetic mothers; andtioxidant protection$302,758
R01 · FY2007 · DK
Mechanisms of Antibody-Mediated Toxin Neutralization$290,530
R01 · FY2008 · AI
B-cells in pups of mild and severe STZ diabetic mothers; andtioxidant protection$290,307
R01 · FY2008 · DK
B-cells in pups of mild and severe STZ diabetic mothers; andtioxidant protection$286,356
R01 · FY2009 · DK